ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesalazine Suppositories Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-3W18332
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mesalazine Suppositories Market Research Report 2024
BUY CHAPTERS

Global Mesalazine Suppositories Market Research Report 2024

Code: QYRE-Auto-3W18332
Report
September 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Salix Pharmaceuticals
Vendors
Mylan N.V.
Ferring Pharmaceuticals
AbbVie
Teva Pharmaceutical Industries
Zambon

Mesalazine Suppositories Market

Mesalazine is an aminosalicylic acid anti-inflammatory drug used to treat inflammatory bowel diseases, including ulcerative colitis, proctitis, Crohn's disease, etc.
The global Mesalazine Suppositories market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Mesalazine Suppositories is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mesalazine Suppositories is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mesalazine Suppositories include Ferring Pharmaceuticals, AbbVie, Salix Pharmaceuticals, Teva Pharmaceutical Industries, Zambon, Mylan N.V., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalazine Suppositories, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine Suppositories.
The Mesalazine Suppositories market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Mesalazine Suppositories market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalazine Suppositories manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mesalazine Suppositories Market Report

Report Metric Details
Report Name Mesalazine Suppositories Market
Segment by Type
  • 1g
  • 0.5g
  • 0.25g
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ferring Pharmaceuticals, AbbVie, Salix Pharmaceuticals, Teva Pharmaceutical Industries, Zambon, Mylan N.V.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mesalazine Suppositories manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mesalazine Suppositories in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mesalazine Suppositories Market report?

Ans: The main players in the Mesalazine Suppositories Market are Ferring Pharmaceuticals, AbbVie, Salix Pharmaceuticals, Teva Pharmaceutical Industries, Zambon, Mylan N.V.

What are the Application segmentation covered in the Mesalazine Suppositories Market report?

Ans: The Applications covered in the Mesalazine Suppositories Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Mesalazine Suppositories Market report?

Ans: The Types covered in the Mesalazine Suppositories Market report are 1g, 0.5g, 0.25g

Recommended Reports

IBD & Gut Drugs

Suppository & API

Bowel Symptom Relief

1 Mesalazine Suppositories Market Overview
1.1 Product Definition
1.2 Mesalazine Suppositories by Type
1.2.1 Global Mesalazine Suppositories Market Value Comparison by Type (2024-2030)
1.2.2 1g
1.2.3 0.5g
1.2.4 0.25g
1.3 Mesalazine Suppositories by Application
1.3.1 Global Mesalazine Suppositories Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mesalazine Suppositories Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Suppositories Revenue 2019-2030
1.4.2 Global Mesalazine Suppositories Sales 2019-2030
1.4.3 Global Mesalazine Suppositories Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mesalazine Suppositories Market Competition by Manufacturers
2.1 Global Mesalazine Suppositories Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mesalazine Suppositories Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mesalazine Suppositories Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Mesalazine Suppositories, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mesalazine Suppositories, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mesalazine Suppositories, Product Type & Application
2.7 Global Key Manufacturers of Mesalazine Suppositories, Date of Enter into This Industry
2.8 Global Mesalazine Suppositories Market Competitive Situation and Trends
2.8.1 Global Mesalazine Suppositories Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mesalazine Suppositories Players Market Share by Revenue
2.8.3 Global Mesalazine Suppositories Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesalazine Suppositories Market Scenario by Region
3.1 Global Mesalazine Suppositories Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mesalazine Suppositories Sales by Region: 2019-2030
3.2.1 Global Mesalazine Suppositories Sales by Region: 2019-2024
3.2.2 Global Mesalazine Suppositories Sales by Region: 2025-2030
3.3 Global Mesalazine Suppositories Revenue by Region: 2019-2030
3.3.1 Global Mesalazine Suppositories Revenue by Region: 2019-2024
3.3.2 Global Mesalazine Suppositories Revenue by Region: 2025-2030
3.4 North America Mesalazine Suppositories Market Facts & Figures by Country
3.4.1 North America Mesalazine Suppositories Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mesalazine Suppositories Sales by Country (2019-2030)
3.4.3 North America Mesalazine Suppositories Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mesalazine Suppositories Market Facts & Figures by Country
3.5.1 Europe Mesalazine Suppositories Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mesalazine Suppositories Sales by Country (2019-2030)
3.5.3 Europe Mesalazine Suppositories Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalazine Suppositories Market Facts & Figures by Region
3.6.1 Asia Pacific Mesalazine Suppositories Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mesalazine Suppositories Sales by Region (2019-2030)
3.6.3 Asia Pacific Mesalazine Suppositories Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mesalazine Suppositories Market Facts & Figures by Country
3.7.1 Latin America Mesalazine Suppositories Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mesalazine Suppositories Sales by Country (2019-2030)
3.7.3 Latin America Mesalazine Suppositories Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mesalazine Suppositories Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalazine Suppositories Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mesalazine Suppositories Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mesalazine Suppositories Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalazine Suppositories Sales by Type (2019-2030)
4.1.1 Global Mesalazine Suppositories Sales by Type (2019-2024)
4.1.2 Global Mesalazine Suppositories Sales by Type (2025-2030)
4.1.3 Global Mesalazine Suppositories Sales Market Share by Type (2019-2030)
4.2 Global Mesalazine Suppositories Revenue by Type (2019-2030)
4.2.1 Global Mesalazine Suppositories Revenue by Type (2019-2024)
4.2.2 Global Mesalazine Suppositories Revenue by Type (2025-2030)
4.2.3 Global Mesalazine Suppositories Revenue Market Share by Type (2019-2030)
4.3 Global Mesalazine Suppositories Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mesalazine Suppositories Sales by Application (2019-2030)
5.1.1 Global Mesalazine Suppositories Sales by Application (2019-2024)
5.1.2 Global Mesalazine Suppositories Sales by Application (2025-2030)
5.1.3 Global Mesalazine Suppositories Sales Market Share by Application (2019-2030)
5.2 Global Mesalazine Suppositories Revenue by Application (2019-2030)
5.2.1 Global Mesalazine Suppositories Revenue by Application (2019-2024)
5.2.2 Global Mesalazine Suppositories Revenue by Application (2025-2030)
5.2.3 Global Mesalazine Suppositories Revenue Market Share by Application (2019-2030)
5.3 Global Mesalazine Suppositories Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ferring Pharmaceuticals
6.1.1 Ferring Pharmaceuticals Company Information
6.1.2 Ferring Pharmaceuticals Description and Business Overview
6.1.3 Ferring Pharmaceuticals Mesalazine Suppositories Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ferring Pharmaceuticals Mesalazine Suppositories Product Portfolio
6.1.5 Ferring Pharmaceuticals Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Mesalazine Suppositories Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Mesalazine Suppositories Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Salix Pharmaceuticals
6.3.1 Salix Pharmaceuticals Company Information
6.3.2 Salix Pharmaceuticals Description and Business Overview
6.3.3 Salix Pharmaceuticals Mesalazine Suppositories Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Salix Pharmaceuticals Mesalazine Suppositories Product Portfolio
6.3.5 Salix Pharmaceuticals Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Company Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Mesalazine Suppositories Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceutical Industries Mesalazine Suppositories Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 Zambon
6.5.1 Zambon Company Information
6.5.2 Zambon Description and Business Overview
6.5.3 Zambon Mesalazine Suppositories Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zambon Mesalazine Suppositories Product Portfolio
6.5.5 Zambon Recent Developments/Updates
6.6 Mylan N.V.
6.6.1 Mylan N.V. Company Information
6.6.2 Mylan N.V. Description and Business Overview
6.6.3 Mylan N.V. Mesalazine Suppositories Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan N.V. Mesalazine Suppositories Product Portfolio
6.6.5 Mylan N.V. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalazine Suppositories Industry Chain Analysis
7.2 Mesalazine Suppositories Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalazine Suppositories Production Mode & Process
7.4 Mesalazine Suppositories Sales and Marketing
7.4.1 Mesalazine Suppositories Sales Channels
7.4.2 Mesalazine Suppositories Distributors
7.5 Mesalazine Suppositories Customers
8 Mesalazine Suppositories Market Dynamics
8.1 Mesalazine Suppositories Industry Trends
8.2 Mesalazine Suppositories Market Drivers
8.3 Mesalazine Suppositories Market Challenges
8.4 Mesalazine Suppositories Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Salix Pharmaceuticals
Vendors
Mylan N.V.
Ferring Pharmaceuticals
AbbVie
Teva Pharmaceutical Industries
Zambon
List of Tables
 Table 1. Global Mesalazine Suppositories Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Mesalazine Suppositories Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Mesalazine Suppositories Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Mesalazine Suppositories Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Mesalazine Suppositories Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Mesalazine Suppositories Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Mesalazine Suppositories Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Mesalazine Suppositories Average Price (US$/Ton) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Mesalazine Suppositories, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mesalazine Suppositories, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mesalazine Suppositories, Product Type & Application
 Table 12. Global Key Manufacturers of Mesalazine Suppositories, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mesalazine Suppositories by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine Suppositories as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mesalazine Suppositories Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Mesalazine Suppositories Sales by Region (2019-2024) & (Tons)
 Table 18. Global Mesalazine Suppositories Sales Market Share by Region (2019-2024)
 Table 19. Global Mesalazine Suppositories Sales by Region (2025-2030) & (Tons)
 Table 20. Global Mesalazine Suppositories Sales Market Share by Region (2025-2030)
 Table 21. Global Mesalazine Suppositories Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Mesalazine Suppositories Revenue Market Share by Region (2019-2024)
 Table 23. Global Mesalazine Suppositories Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Mesalazine Suppositories Revenue Market Share by Region (2025-2030)
 Table 25. North America Mesalazine Suppositories Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Mesalazine Suppositories Sales by Country (2019-2024) & (Tons)
 Table 27. North America Mesalazine Suppositories Sales by Country (2025-2030) & (Tons)
 Table 28. North America Mesalazine Suppositories Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Mesalazine Suppositories Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Mesalazine Suppositories Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Mesalazine Suppositories Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Mesalazine Suppositories Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Mesalazine Suppositories Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Mesalazine Suppositories Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Mesalazine Suppositories Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Mesalazine Suppositories Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Mesalazine Suppositories Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Mesalazine Suppositories Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Mesalazine Suppositories Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Mesalazine Suppositories Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Mesalazine Suppositories Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Mesalazine Suppositories Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Mesalazine Suppositories Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Mesalazine Suppositories Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Mesalazine Suppositories Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Mesalazine Suppositories Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Mesalazine Suppositories Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Mesalazine Suppositories Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Mesalazine Suppositories Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Mesalazine Suppositories Sales (Tons) by Type (2019-2024)
 Table 51. Global Mesalazine Suppositories Sales (Tons) by Type (2025-2030)
 Table 52. Global Mesalazine Suppositories Sales Market Share by Type (2019-2024)
 Table 53. Global Mesalazine Suppositories Sales Market Share by Type (2025-2030)
 Table 54. Global Mesalazine Suppositories Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Mesalazine Suppositories Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Mesalazine Suppositories Revenue Market Share by Type (2019-2024)
 Table 57. Global Mesalazine Suppositories Revenue Market Share by Type (2025-2030)
 Table 58. Global Mesalazine Suppositories Price (US$/Ton) by Type (2019-2024)
 Table 59. Global Mesalazine Suppositories Price (US$/Ton) by Type (2025-2030)
 Table 60. Global Mesalazine Suppositories Sales (Tons) by Application (2019-2024)
 Table 61. Global Mesalazine Suppositories Sales (Tons) by Application (2025-2030)
 Table 62. Global Mesalazine Suppositories Sales Market Share by Application (2019-2024)
 Table 63. Global Mesalazine Suppositories Sales Market Share by Application (2025-2030)
 Table 64. Global Mesalazine Suppositories Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Mesalazine Suppositories Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Mesalazine Suppositories Revenue Market Share by Application (2019-2024)
 Table 67. Global Mesalazine Suppositories Revenue Market Share by Application (2025-2030)
 Table 68. Global Mesalazine Suppositories Price (US$/Ton) by Application (2019-2024)
 Table 69. Global Mesalazine Suppositories Price (US$/Ton) by Application (2025-2030)
 Table 70. Ferring Pharmaceuticals Company Information
 Table 71. Ferring Pharmaceuticals Description and Business Overview
 Table 72. Ferring Pharmaceuticals Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 73. Ferring Pharmaceuticals Mesalazine Suppositories Product
 Table 74. Ferring Pharmaceuticals Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 78. AbbVie Mesalazine Suppositories Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. Salix Pharmaceuticals Company Information
 Table 81. Salix Pharmaceuticals Description and Business Overview
 Table 82. Salix Pharmaceuticals Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 83. Salix Pharmaceuticals Mesalazine Suppositories Product
 Table 84. Salix Pharmaceuticals Recent Developments/Updates
 Table 85. Teva Pharmaceutical Industries Company Information
 Table 86. Teva Pharmaceutical Industries Description and Business Overview
 Table 87. Teva Pharmaceutical Industries Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 88. Teva Pharmaceutical Industries Mesalazine Suppositories Product
 Table 89. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 90. Zambon Company Information
 Table 91. Zambon Description and Business Overview
 Table 92. Zambon Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 93. Zambon Mesalazine Suppositories Product
 Table 94. Zambon Recent Developments/Updates
 Table 95. Mylan N.V. Company Information
 Table 96. Mylan N.V. Description and Business Overview
 Table 97. Mylan N.V. Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 98. Mylan N.V. Mesalazine Suppositories Product
 Table 99. Mylan N.V. Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Mesalazine Suppositories Distributors List
 Table 103. Mesalazine Suppositories Customers List
 Table 104. Mesalazine Suppositories Market Trends
 Table 105. Mesalazine Suppositories Market Drivers
 Table 106. Mesalazine Suppositories Market Challenges
 Table 107. Mesalazine Suppositories Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mesalazine Suppositories
 Figure 2. Global Mesalazine Suppositories Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Mesalazine Suppositories Market Share by Type: 2023 & 2030
 Figure 4. 1g Product Picture
 Figure 5. 0.5g Product Picture
 Figure 6. 0.25g Product Picture
 Figure 7. Global Mesalazine Suppositories Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Mesalazine Suppositories Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Mesalazine Suppositories Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Mesalazine Suppositories Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Mesalazine Suppositories Sales (2019-2030) & (Tons)
 Figure 15. Global Mesalazine Suppositories Average Price (US$/Ton) & (2019-2030)
 Figure 16. Mesalazine Suppositories Report Years Considered
 Figure 17. Mesalazine Suppositories Sales Share by Manufacturers in 2023
 Figure 18. Global Mesalazine Suppositories Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Mesalazine Suppositories Players: Market Share by Revenue in Mesalazine Suppositories in 2023
 Figure 20. Mesalazine Suppositories Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Mesalazine Suppositories Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Mesalazine Suppositories Sales Market Share by Country (2019-2030)
 Figure 23. North America Mesalazine Suppositories Revenue Market Share by Country (2019-2030)
 Figure 24. United States Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Mesalazine Suppositories Sales Market Share by Country (2019-2030)
 Figure 27. Europe Mesalazine Suppositories Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Mesalazine Suppositories Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Mesalazine Suppositories Revenue Market Share by Region (2019-2030)
 Figure 35. China Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Mesalazine Suppositories Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Mesalazine Suppositories Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Mesalazine Suppositories Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Mesalazine Suppositories Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Mesalazine Suppositories by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Mesalazine Suppositories by Type (2019-2030)
 Figure 54. Global Mesalazine Suppositories Price (US$/Ton) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Mesalazine Suppositories by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Mesalazine Suppositories by Application (2019-2030)
 Figure 57. Global Mesalazine Suppositories Price (US$/Ton) by Application (2019-2030)
 Figure 58. Mesalazine Suppositories Value Chain
 Figure 59. Mesalazine Suppositories Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Mesalazine Market Research Report 2024
Global Mesalazine API Market Research Report 2025
Oral Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rectal Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalamine Market Research Report 2024
Global Mesalamine API Market Research Report 2024
Mesalamine Lialda Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
5 aminosalicylic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug for Ulcerative Colitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalazine Enteric Coated Tablets Market Research Report 2024
Global Diclofenac Sodium Suppositories Market Research Report 2025
Global Aminosalicylic Acid Preparation Market Insights Forecast to 2030
Global Balsalazide Disodium Market Research Report 2025
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Global IBD Ulcerative Colitis and Crohn s Disease Treatment Market Insights Forecast to 2030
Global Sulfapyridine Market Research Report 2024
Inflammatory Bowel Disease IBD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Salicylsalicylic Acid Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions